Wave Life Sciences Ltd. (WVE) Cash Flow Statement
Wave Life Sciences Ltd. (WVE) generated -$191.6M of operating cash flow over the twelve months to 2026-06-30, spent $1.6M on capital expenditure and had free cash flow of -$193.1M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
WVEWave Life Sciences Ltd.Follow WVE — free
—
Price chart with a free account
- Market cap
- 626.6M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 9 Nov, in 16 days
| Line | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -12.5 | -31.9 | -83.7 | -22.9 | -188.2 | -116.0 | -89.0 | -127.8 | -19.4 | -151.0 | -187.5 | -191.6 | |
| Capital expenditure | 1.9 | 5.6 | 18.9 | 9.9 | 3.9 | 1.3 | 0.6 | 1.4 | 1.1 | 0.9 | 0.7 | -1.6 | |
| Free cash flow | -14.4 | -37.4 | -102.6 | -32.8 | -192.1 | -117.3 | -89.6 | -129.1 | -20.5 | -152.0 | -188.2 | -193.1 | |
| Stock-based compensation | 4.0 | — | — | — | — | — | — | — | — | — | — | — |
USD millions · SEC XBRL
Wave Life Sciences Ltd. — questions
- What is Wave Life Sciences Ltd.'s operating cash flow?
- -$191.6M over the twelve months to 2026-06-30.
- How much does Wave Life Sciences Ltd. spend on capital expenditure?
- $1.6M over the twelve months to 2026-06-30.
- What is Wave Life Sciences Ltd.'s free cash flow?
- -$193.1M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Wave Life Sciences Ltd.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.